Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study (Q42202756)
Jump to navigation
Jump to search
scientific article published on 28 July 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study |
scientific article published on 28 July 2014 |
Statements
1 reference
Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study (English)
1 reference
Sivi Ouwerkerk-Mahadevan
1 reference
Mark S Sulkowski
1 reference
Eric Lawitz
1 reference
Reem Ghalib
1 reference
Maribel Rodriguez-Torres
1 reference
Zobair M Younossi
1 reference
Ana Corregidor
1 reference
Edwin DeJesus
1 reference
Brian Pearlman
1 reference
Mordechai Rabinovitz
1 reference
Norman Gitlin
1 reference
Joseph K Lim
1 reference
Paul J Pockros
1 reference
John D Scott
1 reference
Bart Fevery
1 reference
Tom Lambrecht
1 reference
Katleen Callewaert
1 reference
William T Symonds
1 reference
Gaston Picchio
1 reference
Karen L Lindsay
1 reference
Maria Beumont
1 reference
Ira M Jacobson
1 reference
28 July 2014
1 reference
Identifiers
1 reference